{
  "retracted": true,
  "timestamp": 1437436800000,
  "updates": [
    {
      "timestamp": 1586598035220,
      "identifier": {
        "doi": "10.1007/s12032-015-0661-4"
      },
      "type": "retraction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s12032-014-0251-x"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Retraction Note to: A randomized phase II study of everolimus for advanced pancreatic neuroendocrine tumors in Chinese patients"
}
